Stealth BioTherapeutics (NASDAQ:MITO) released its quarterly earnings results on Monday. The company reported ($0.03) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.01 by ($0.04), MarketWatch Earnings reports.
MITO stock opened at $1.50 on Wednesday. The firm has a market cap of $83.15 million, a price-to-earnings ratio of 37.51 and a beta of 2.25. The firm has a 50-day simple moving average of $1.74 and a two-hundred day simple moving average of $1.54. Stealth BioTherapeutics has a one year low of $1.19 and a one year high of $2.58.
About Stealth BioTherapeutics
Further Reading: Understanding the different types of bonds
Receive News & Ratings for Stealth BioTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stealth BioTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.